The company recently extended the term of its 10-year pharmaceutical distribution agreement with Walgreens Boot Alliance WBA for three years. Click to get this free report BRISTOL-MYERS (BMY): Free Stock Analysis Report IRONWOOD PHARMA (IRWD): Free Stock Analysis Report WALGREENS BAI (WBA): Free Stock Analysis Report AMERISOURCEBRGN (ABC): Free Stock Analysis Report To read this article on Zacks.com click here. Its pharmaceutical distribution segment continues to experience headwinds in the form of contract renewals and lower generic inflation.